Patents by Inventor Gary B. Mosser

Gary B. Mosser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230111214
    Abstract: The present invention relates to biobased polyglyceryl ester compounds and compositions and formulations comprising same, processes for preparing the inventive biobased polyglyceryl ester compositions, as well as applications thereof including the use of the inventive compounds and compositions in formulations of products or components of products. The biobased polyglyceryl ester composition may comprise a mixture including one or more compounds of Formula (I): wherein: PG is a polyglyceryl group comprising greater than 40% hexaglycerol and higher polyglycerols and less than 60% pentaglycerol and lower polyglycerols, R is a linear or branched C5-C8 alkyl group, n=from 1 to 3, and wherein substantially all of the carbon present in the one or more compounds of Formula (I) is biobased.
    Type: Application
    Filed: October 8, 2022
    Publication date: April 13, 2023
    Applicant: Inolex Investment Corporation
    Inventors: Michael J. Fevola, Gary B. Mosser, Brittany M. Pease, Zongyu Zhang
  • Publication number: 20220402844
    Abstract: A process is incorporated herein for the synthesis of bio-1,2-alkanediols, comprising: providing a bio-alkene having a carbon chain of about 5 to about 20 carbon atoms and a bio-1-alkene regioselectivity of at least about 80%, at least about 92% and/or at least about 95%; and converting the bio-alkene to a bio-1,2-alkanediol having a carbon chain length of about 5 to about 20 carbon atoms. Methods for treating catalysts which may be incorporated in the process for the synthesis of bio-1,2-alkanediols are also included herein. Such bio-1,2-alkanediols are used in compositions and products alone as antimicrobial materials, or with existing bio-compounds and/or antimicrobials, preservatives, alternative preservation systems and/or hurdle technology components. The bio-1,2-alkanediols incorporate a natural and bio-based pathway for antimicrobial effects in various compositions such as cosmetic, pharmaceutical, industrial and household products.
    Type: Application
    Filed: June 24, 2022
    Publication date: December 22, 2022
    Inventors: Rocco V. Burgo, Michael E. Wright, Gary B. Mosser, Michael J. Fevola
  • Patent number: 11414365
    Abstract: A process is incorporated herein for the synthesis of bio-1,2-alkanediols, comprising: providing a bio-alkene having a carbon chain of about 5 to about 20 carbon atoms and a bio-1-alkene regioselectivity of at least about 80%, at least about 92% and/or at least about 95%; and converting the bio-alkene to a bio-1,2-alkanediol having a carbon chain length of about 5 to about 20 carbon atoms. Methods for treating catalysts which may be incorporated in the process for the synthesis of bio-1,2-alkanediols are also included herein. Such bio-1,2-alkanediols are used in compositions and products alone as antimicrobial materials, or with existing bio-compounds and/or antimicrobials, preservatives, alternative preservation systems and/or hurdle technology components. The bio-1,2-alkanediols incorporate a natural and bio-based pathway for antimicrobial effects in various compositions such as cosmetic, pharmaceutical, industrial and household products.
    Type: Grant
    Filed: January 30, 2019
    Date of Patent: August 16, 2022
    Assignee: INOLEX INVESTMENT CORPORATION
    Inventors: Rocco V. Burgo, Michael E. Wright, Gary B. Mosser, Michael J. Fevola
  • Publication number: 20220135769
    Abstract: The present invention relates to biobased glyceryl heptanoate compositions, and preferably glyceryl monoheptanoate compositions, methods of manufacturing the same, as well as applications thereof including the use of the inventive compositions in formulations for cosmetics and other personal care applications. The biobased monoglyceryl monoester (MGME) compositions include a mixture including one or more compounds of Formula (I): R1, R2, and R3 are independently —H or —C(O)—C6 alkyl. The composition comprises greater than about 60 wt % and less than about 98 wt % glyceryl monoheptanoate. The carbon present in the one or more compounds of Formula (I) is biobased. The composition has an ET50 value of >24 hr when tested as a 1% solution in water according to the EpiDerm Skin Irritation Test (OECD 439). The present invention also relates to microbiostatic concentrates (MBCs) including the disclosed composition.
    Type: Application
    Filed: November 4, 2021
    Publication date: May 5, 2022
    Applicant: INOLEX INVESTMENT CORPORATION
    Inventors: Michael J. Fevola, Gary B. Mosser, Zongyu Zhang
  • Patent number: 10995048
    Abstract: A process is incorporated herein for the synthesis of bio-1,2-alkanediols, comprising: providing a bio-alkene having a carbon chain of about 5 to about 20 carbon atoms and a bio-1-alkene regioselectivity of at least about 80%, at least about 92% and/or at least about 95%; and converting the bio-alkene to a bio-1,2-alkanediol having a carbon chain length of about 5 to about 20 carbon atoms. Methods for treating catalysts which may be incorporated in the process for the synthesis of bio-1,2-alkanediols are also included herein. Such bio-1,2-alkanediols are used in compositions and products alone as antimicrobial materials, or with existing bio-compounds and/or antimicrobials, preservatives, alternative preservation systems and/or hurdle technology components. The bio-1,2-alkanediols incorporate a natural and bio-based pathway for antimicrobial effects in various compositions such as cosmetic, pharmaceutical, industrial and household products.
    Type: Grant
    Filed: November 13, 2019
    Date of Patent: May 4, 2021
    Assignee: INOLEX INVESTMENT CORPORATION
    Inventors: Rocco V. Burgo, Michael E. Wright, Gary B. Mosser, Michael J. Fevola
  • Patent number: 10882803
    Abstract: A process is incorporated herein for the synthesis of bio-1,2-alkanediols, comprising: providing a bio-alkene having a carbon chain of about 5 to about 20 carbon atoms and a bio-1-alkene regioselectivity of at least about 80%, at least about 92% and/or at least about 95%; and converting the bio-alkene to a bio-1,2-alkanediol having a carbon chain length of about 5 to about 20 carbon atoms. Methods for treating catalysts which may be incorporated in the process for the synthesis of bio-1,2-alkanediols are also included herein. Such bio-1,2-alkanediols are used in compositions and products alone as antimicrobial materials, or with existing bio-compounds and/or antimicrobials, preservatives, alternative preservation systems and/or hurdle technology components. The bio-1,2-alkanediols incorporate a natural and bio-based pathway for antimicrobial effects in various compositions such as cosmetic, pharmaceutical, industrial and household products.
    Type: Grant
    Filed: January 30, 2019
    Date of Patent: January 5, 2021
    Assignee: INOLEX INVESTMENT CORPORATION
    Inventors: Rocco V. Burgo, Michael E. Wright, Gary B. Mosser, Michael J. Fevola
  • Publication number: 20200189995
    Abstract: A process is incorporated herein for the synthesis of bio-1,2-alkanediols, comprising: providing a bio-alkene having a carbon chain of about 5 to about 20 carbon atoms and a bio-1-alkene regioselectivity of at least about 80%, at least about 92% and/or at least about 95%; and converting the bio-alkene to a bio-1,2-alkanediol having a carbon chain length of about 5 to about 20 carbon atoms. Methods for treating catalysts which may be incorporated in the process for the synthesis of bio-1,2-alkanediols are also included herein. Such bio-1,2-alkanediols are used in compositions and products alone as antimicrobial materials, or with existing bio-compounds and/or antimicrobials, preservatives, alternative preservation systems and/or hurdle technology components. The bio-1,2-alkanediols incorporate a natural and bio-based pathway for antimicrobial effects in various compositions such as cosmetic, pharmaceutical, industrial and household products.
    Type: Application
    Filed: November 13, 2019
    Publication date: June 18, 2020
    Inventors: Rocco V. Burgo, Michael E. Wright, Gary B. Mosser, Michael J. Fevola
  • Publication number: 20190289848
    Abstract: A process is incorporated herein for the synthesis of bio-1,2-alkanediols, comprising: providing a bio-alkene having a carbon chain of about 5 to about 20 carbon atoms and a bio-1-alkene regioselectivity of at least about 80%, at least about 92% and/or at least about 95%; and converting the bio-alkene to a bio-1,2-alkanediol having a carbon chain length of about 5 to about 20 carbon atoms. Methods for treating catalysts which may be incorporated in the process for the synthesis of bio-1,2-alkanediols are also included herein. Such bio-1,2-alkanediols are used in compositions and products alone as antimicrobial materials, or with existing bio-compounds and/or antimicrobials, preservatives, alternative preservation systems and/or hurdle technology components. The bio-1,2-alkanediols incorporate a natural and bio-based pathway for antimicrobial effects in various compositions such as cosmetic, pharmaceutical, industrial and household products.
    Type: Application
    Filed: January 30, 2019
    Publication date: September 26, 2019
    Inventors: Rocco V. Burgo, Michael E. Wright, Gary B. Mosser, Michael J. Fevola
  • Publication number: 20190241491
    Abstract: A process is incorporated herein for the synthesis of bio-1,2-alkanediols, comprising: providing a bio-alkene having a carbon chain of about 5 to about 20 carbon atoms and a bio-1-alkene regioselectivity of at least about 80%, at least about 92% and/or at least about 95%; and converting the bio-alkene to a bio-1,2-alkanediol having a carbon chain length of about 5 to about 20 carbon atoms. Methods for treating catalysts which may be incorporated in the process for the synthesis of bio-1,2-alkanediols are also included herein. Such bio-1,2-alkanediols are used in compositions and products alone as antimicrobial materials, or with existing bio-compounds and/or antimicrobials, preservatives, alternative preservation systems and/or hurdle technology components. The bio-1,2-alkanediols incorporate a natural and bio-based pathway for antimicrobial effects in various compositions such as cosmetic, pharmaceutical, industrial and household products.
    Type: Application
    Filed: January 30, 2019
    Publication date: August 8, 2019
    Inventors: Rocco V. Burgo, Michael E. Wright, Gary B. Mosser, Michael J. Fevola